Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2010
12/23/2010US20100323038 Pharmaceutical Compositions
12/23/2010US20100323023 Composition for the treatment of a detached retina and method of production thereof
12/23/2010US20100322997 Method for producing biologically ingestible microparticles, biologically ingestible microparticles, and dispersion and pharmaceutical composition containing the same
12/23/2010US20100322973 Anti-allergic agent
12/23/2010US20100322947 Pharmaceutical composition for treating avellino cornea dystrophy comprising an antibody against tgf-beta
12/23/2010US20100322931 Anti-vegf antibodies and their uses
12/23/2010US20100322930 Fibronectin-based binding molecules and their use
12/23/2010US20100322863 Methods and Uses of Anti-IL-23 Antibodies
12/23/2010DE202010014503U1 Wässrige Lösung zum Spülen von Geweben oder Organen Aqueous solution for rinsing of tissues or organs
12/23/2010CA2803059A1 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
12/23/2010CA2767895A1 Opsin-binding ligands, compositions and methods of use
12/23/2010CA2764124A1 Substituted isoquinoline derivative
12/22/2010EP2264052A2 Activatable recombinant neurotoxins
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263674A1 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
12/22/2010EP2263648A1 Ophthalmic composition
12/22/2010EP2262815A1 Inhibitors of protein tyrosine kinase activity
12/22/2010EP2262524A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability
12/22/2010EP2262519A2 Treatment of hearing and balance impairments with redox-active therapeutics
12/22/2010EP2262515A2 Use of black soybean for treating ophthalmic diseases
12/22/2010EP2262506A1 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
12/22/2010EP2262476A1 Drug delivery to the anterior and posterior segments of the eye using eye drops.
12/22/2010EP1651232B1 Compounds for inflammation and immune-related uses
12/22/2010EP1392696B1 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro 2,3-b quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide
12/22/2010EP1368013B1 Cyclohexenone derivative for treating diabetic neuropathy
12/22/2010EP1364660B1 Drug-releasing system of biodegradable polymer type
12/22/2010EP1214064B1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
12/22/2010CN1662242B Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/22/2010CN1547477B Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
12/22/2010CN101925584A Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, HIV, HPV, bacterial infections and dermatosis
12/22/2010CN101925347A Polysaccharide gel compositions and methods for sustained delivery of drugs
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921695A Liver-benefiting eye-brightening liquor
12/22/2010CN101921279A Spirocyclic heterocyclic derivatives and methods of their use
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101920019A Hydrophilic polymer-puerarin specific conjugated non-hemolytic conjugate
12/22/2010CN101919971A Agent for locally preventing and treating body surface diseases
12/22/2010CN101919810A Dexpanthenol infusion preparation and preparation method thereof
12/22/2010CN101919809A New dexpanthenol injection preparation and preparation method thereof
12/22/2010CN101390943B Traditional Chinese medicine preparation for improving acuity of vision and emoving nebula, tranquilizing and allaying excitement, reducing fever and nourishing liver and preparation method thereof
12/22/2010CN101371925B Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof
12/22/2010CN101185645B Cromoglyn sodium gel eyedrop and preparation method
12/21/2010US7855222 indazole derivatives such as 5-[4-(1-amino-1-methylethyl)phenyl]-1H-indazole, used for the treatment of vision defects
12/21/2010US7855197 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
12/21/2010CA2483345C Imidazolinylmethyl aralkylsulfonamides
12/21/2010CA2453823C Dermal therapy using phosphate derivatives of electron transfer agents
12/21/2010CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds
12/16/2010WO2010143990A1 Pharmaceutical composition for use in medical and veterinary ophthalmology
12/16/2010WO2010143708A1 Targeting agent for neovascularization
12/16/2010WO2010143435A1 Vaccine therapy for choroidal neovascularization
12/16/2010WO2010143065A1 Compositions and methods for increasing lifespan and health span
12/16/2010WO2010142040A1 Novel netrin derivatives and uses thereof
12/16/2010US20100317725 Choline Esters
12/16/2010US20100317718 Modulation of hif1 beta expression
12/16/2010US20100317710 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
12/16/2010US20100317666 Composition Comprising An NK-1 Receptor Antagonist And An SSRI For The Treatment Of Tinnitus And Hearing Loss
12/16/2010US20100317655 Sulfonamide inhibitors of carbonic anhydrase
12/16/2010US20100317615 Method of enhancing ocular penetration of a drug in an eyedrop
12/16/2010US20100317586 Method for topical treatment of eye disease and composition and device for said treatment
12/16/2010US20100317575 Pharmaceutical composition comprising a pyrazole-o-glucoside derivative
12/16/2010US20100316731 Treatment of age-related macular degeneration
12/16/2010US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers
12/16/2010US20100316652 Vascular endothelial cell growth factor antagonists
12/16/2010US20100316638 Antibody Formulations and Use Thereof
12/16/2010CA2764562A1 Vaccine therapy for choroidal neovascularization
12/16/2010CA2764481A1 Pharmaceutical composition for use in medical and veterinary ophthalmology
12/15/2010EP2261358A2 Novel streptococcus antigen
12/15/2010EP2261249A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261248A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261247A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261210A1 3-substituted sulfonyl piperazine derivative
12/15/2010EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor
12/15/2010EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents
12/15/2010EP2260848A1 Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid
12/15/2010EP2260847A1 Aqueous liquid containing gatifloxacin
12/15/2010EP1761253B1 Hyaluronic acid in the enhancement of lens regeneration
12/15/2010EP1635855B1 Selective r-cadherin antagonists and methods
12/15/2010EP1558254B1 Use of 4-aminoquinolines compounds for the treatment of inflammatory disorders of the eye
12/15/2010EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
12/15/2010EP1534667B1 Muscarinic agonists
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010EP1404174B1 Anti-infective compositions for treating disordered tissue such as cold sores
12/15/2010CN1939357B Preparation of Ginkgo Damo injection
12/15/2010CN1933840B Use of a phenothiazine derivative for preventing and/or treating hearing loss
12/15/2010CN1547475B Dermal therapy using phosphate derivatives of electron transfer agents
12/15/2010CN101918444A Anti-factor B antibodies and their uses
12/15/2010CN101918366A Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
12/15/2010CN101914109A Boron-containing small molecules
12/15/2010CN101914065A Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by crth2
12/15/2010CN101912547A Medicament for treating dizziness and preparation method thereof
12/15/2010CN101912490A Traditional Chinese medical preparation for treating otitis media
12/15/2010CN101912465A Preparation method and application of sanguisorba antiphlogistic, analgesic, antiviral and anti-infective dressing
12/15/2010CN101912420A Method for preparing pearl powder Chinese medicinal decocting pieces
12/15/2010CN101912416A Method for preparing superfine antelope horn powder
12/15/2010CN101912380A Compounds for the treatment of metabolic disorders
12/15/2010CN101912355A Recombinant human interleukin-1 receptor antagonist in-situ gel
12/15/2010CN101390834B Eye amphotericin B flexible liposome
12/15/2010CN101342291B Chinese medicinal composition for preventing and controlling hypometropia, and preparation method
12/15/2010CN101297864B Preparation of Xia sang ju formulation
12/15/2010CN101199600B Chinese medicine for treating nephrasthenia tinnitus
1 ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 ... 531